<DOC>
	<DOCNO>NCT01512563</DOCNO>
	<brief_summary>Paclitaxel cover metal biliary stent extent patency rate compare Common Covered Metallic Biliary Stent .</brief_summary>
	<brief_title>Patency Safety Drug Eluting Covered Biliary Stent Comparing Common Covered Biliary Stent</brief_title>
	<detailed_description>Paclitaxel cover metal biliary stent ( Mira-Cover Biliary Stent ) extents patency rate compare Common Covered Metallic Biliary Stent ( Niti-S Biliary Stent .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patient inoperable and/or unresectable case pancreatic cancer and/or biliary cancer mid distal CBD invasion Among patient a. , Patient previously surgical biliary drainage plastic stent eligibility Patient life expectancy 3 month Patient severe metastasis Liver whole body Patient previously surgical biliary drainage</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>paclitaxel</keyword>
	<keyword>drug elute stent</keyword>
</DOC>